Lung transplant patients aim for aconcagua summit in landmark altitude study

NCT ID NCT07479511

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study follows 30 lung transplant recipients and healthy volunteers as they prepare for and climb Mount Aconcagua (6,971 meters). Participants first use a special tent at home for eight weeks to get used to lower oxygen levels. Then, a team monitors their lung function, oxygen levels, and symptoms during the actual climb. The goal is to learn how well transplant lungs adapt to extreme altitude and whether such expeditions are safe.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
intermittent hypoxic conditioning via normobaric hypoxic tent
What this could lead to
If successful, this could show that lung transplant recipients can safely adapt to extreme altitudes, potentially improving their physical fitness and quality of life.
What could go wrong
This is a small observational study (30 participants) with no control group for the intervention. High-altitude exposure carries risks like acute mountain sickness, and results may not apply to all transplant recipients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALTITUDE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of Vienna

    Vienna, State of Vienna, 1090, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.